News

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer. 

Congress Money washington DC legislation coverage payment

Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.

heart surgery cardiac surgeons

There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.

FDA recall medical device recall product recall

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

Prenuvo MRI

Sean Clifford filed the lawsuit Sept. 24, 2024, in the New York State Supreme Court, contending a radiologist failed to spot signs of a forthcoming stroke.   

insurance insurer payment claim denial reimbursement prior authorization

This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology. 

IV hospital room intravenous drip solution

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

healthcare surprise billing statement payment

A new analysis claims the “benchmark” qualifying payment amount insurers calculate often “dramatically” understates the actual median in-network rates they are paying for in-network care.  

RadNet CEO Howard Berger

On a same-center basis, MRI volumes increased nearly 12% year over year, while CT grew by 10%, and PET/CT leapt 14%, the Los Angeles-based company said Wednesday.  

The Danish pharmaceutical company said it will resubmit its application in 2025 to have Wegovy approved for use in heart failure patients.

A survey from KFF survey found the spike in cost will be mitigated by subsidies. However, the number of uninsured Americans could rise.

Huxley Medical, an Atlanta-based medical device company, has secured U.S. Food and Drug Administration (FDA) clearance for its new Sansa device, a chest-worn patch designed to help diagnose sleep apnea in addition to tracking patient data with electrocardiograms (ECGs) a variety of sensors.

The new device from Huxley Medical offers care teams a way to monitor patients for signs of sleep apnea while also keeping a close eye on their heart health. 

Around the web

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.